Andrew Kaufman, MD
Interventional Pain Medicine · Newark, NJNPI 1437201332
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,863 of the $8,967 with a category attached, or 76.5%. It is spread thinly across 27 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations.
Across 119 payments — averaging $75.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$2K
- Medtronic$1K
- Vertiflex, Inc.$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$857
- Abbott$844
- Nevro Corp.$473
- plus $3K from 21 others
What the payments were for
- Speaking & faculty fees$85710%
- Travel & lodging$1,23414%
- Food & beverage$6,86377%
- Entertainment$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 16 | $1,750 |
| Medtronic(2 entities) | 20 | $1,192 |
| Vertiflex, Inc. | 5 | $1,066 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $857 |
| Abbott | 12 | $844 |
| Nevro Corp. | 6 | $473 |
| Foundation Fusion Solutions, LLC | 9 | $464 |
| Boston Scientific | 4 | $318 |
| SPR Therapeutics, Inc | 2 | $262 |
| Bioventus LLC | 3 | $199 |
| AbbVie(2 entities) | 12 | $189 |
| Globus Medical | 4 | $179 |
| Sanara Medtech Inc. | 1 | $145 |
| GRT US Holding, Inc. | 1 | $140 |
| Kowa Pharmaceuticals America, Inc. | 2 | $137 |
| Next Science LLC | 1 | $135 |
| Relievant Medsystems, Inc. | 3 | $108 |
| Curonix LLC | 1 | $98 |
| Nalu Medical, Inc. | 3 | $83 |
| Tonix Medicines, Inc. | 1 | $77 |
| Stimwave Technologies Incorporated | 1 | $63 |
| Avanos Medical | 3 | $58 |
| Averitas Pharma Inc. | 3 | $51 |
| Biotronik NRO, Inc. | 1 | $26 |
| Vertos Medical, Inc. | 1 | $24 |
| IBSA Pharma Inc. | 2 | $24 |
| Saluda Medical Americas, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIFUSE$1,212
- Superion ISS$964
- RELISTOR$857
- Proclaim Family of SCS IPGs$584
- INTELLIS$363
- Senza Spinal Cord Stimulation System$219
- SPRINT PNS System$180
- GENERAL PAIN MANAGEMENT$166
- CellerateRx$145
- Qutenza$140
- SurgX$135
- Xperience$135
- BlastX$135
- SYNCHROMEDII$129
- Seglentis$125
- FLOSEAL$123
- INCEPTIV$120
- VECTRIS$118
- CORRIDOR$117
- Senza$115
How this compares
$8,967 in reported general payments places this provider in the 75th percentile of 82 interventional pain medicine providers in New Jersey.
See all interventional pain medicine providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 67 | $12,340 |
| OxycontinOxycodone Hcl | 24 | $9,011 |
| Nucynta ErTapentadol Hcl | 11 | $3,682 |
| NucyntaTapentadol Hcl | 11 | $3,519 |
| Gabapentin | 209 | $2,590 |
| Methadone Hcl | 151 | $1,987 |
| Oxycodone Hcl | 62 | $1,334 |
| Pregabalin | 59 | $1,231 |
| Hydromorphone Hcl | 92 | $1,189 |
| Oxcarbazepine | 47 | $1,013 |
| Tizanidine Hcl | 32 | $832 |
| Baclofen | 49 | $642 |
| Tramadol Hcl | 63 | $585 |
| Tramadol Hcl ErTramadol Hcl | 11 | $482 |
| Duloxetine Hcl | 23 | $467 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Newark
- Adam KenneyNewark$5K
- Youssef JosephsonWest Deptford$496K
- Ali ValimahomedHolmdel$415K
- Saurabh DangEdgewater$157K
- Gabriele JasperBrick$114K
- Matthew LippChatham$67K
- Didier DemesminSomerset$33K
- Steve AydinFranklin Lakes$22K
- Kieran SlevinHainesport$21K
- John CoccaroToms River$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.